Postpartum Care Practice Questions

Q: All of the following drugs are used for prevention of PPH, EXCEPT:

Dinoprostone. ***Dinoprostone*** - **Dinoprostone** is a prostaglandin E2 analog primarily used for **cervical ripening** and **labor induction**. - While it can cause uterine contractions, it is **not commonly used** for the prevention or treatment of postpartum hemorrhage (PPH) because other uterotonics are more effective and have a better safety profile for this specific indication. *Misoprostol* - **Misoprostol** is a synthetic prostaglandin E1 analog and is a highly effective uterotonic agent used for both the **prevention and treatment of PPH**. - It works by inducing **strong uterine contractions**, which helps to reduce blood loss after delivery. *Oxytocin* - **Oxytocin** is the first-line and most common uterotonic agent used for the **prevention and treatment of PPH**. - It causes rapid and sustained **uterine contractions**, which compress blood vessels in the uterus and prevent excessive bleeding. *PGF-2 alpha* - **PGF-2 alpha**, specifically **Carboprost tromethamine** (Hemabate), is a prostaglandin F2 alpha analog used to **treat PPH** when other agents like oxytocin are ineffective or contraindicated. - It induces **powerful uterine contractions** and is often reserved for severe cases of PPH.

Q: A 28-year-old postpartum woman presents with uterine atony and heavy bleeding. Which medication should be avoided due to a history of hypertension?

Methylergonovine. ***Methylergonovine*** - **Methylergonovine** is contraindicated in patients with **hypertension** due to its potent vasoconstrictive effect, which can lead to a hypertensive crisis, stroke, or myocardial infarction. - This medication should be avoided in a postpartum woman with a history of hypertension to prevent severe cardiovascular complications while treating uterine atony. *Carboprost* - **Carboprost** is a prostaglandin F2-alpha analog that can cause **bronchoconstriction** and is contraindicated in patients with asthma. - While it can cause transient hypertension, it is generally considered safer than methylergonovine in patients with a history of hypertension. *Misoprostol* - **Misoprostol** is a synthetic prostaglandin E1 analog that can be safely used in patients with hypertension. - Its primary side effects include **diarrhea**, shivering, and fever, rather than significant cardiovascular effects. *Oxytocin* - **Oxytocin** is the first-line uterotonic agent for preventing and treating postpartum hemorrhage and is safe to use in patients with hypertension. - While large doses can cause **hypotension** and **tachycardia**, it does not typically exacerbate pre-existing hypertension.

Q: A 28-year-old woman, G2 P1, with severe PPH unresponsive to oxytocin presents with hypotension and tachycardia. She has a soft uterus and ongoing bleeding. What is the next best step in management?

IM carboprost. ***IM carboprost*** - The **soft uterus** with ongoing bleeding despite oxytocin indicates **uterine atony** as the cause of PPH - Carboprost (PGF2α) is the **standard second-line uterotonic agent** after oxytocin failure - Effectively stimulates strong **uterine contractions** to control hemorrhage from the placental bed - Given intramuscularly at **0.25 mg every 15-90 minutes** (maximum 8 doses) - Contraindicated in active cardiac, pulmonary, or hepatic disease *Immediate hysterectomy* - Peripartum hysterectomy is a **last-resort surgical intervention** for refractory PPH - Should only be performed after failure of medical management (all uterotonics) and conservative surgical options (uterine tamponade, uterine artery ligation, B-Lynch suture) - **Too aggressive** as the immediate next step when second-line uterotonics haven't been tried *Expectant management* - **Completely inappropriate** for severe PPH with hemodynamic instability (hypotension, tachycardia) - Ongoing bleeding from uterine atony requires **immediate aggressive intervention** - Delays increase risk of hypovolemic shock, DIC, maternal morbidity, and mortality *IV tranexamic acid* - **Antifibrinolytic agent** that inhibits plasminogen activation, promoting clot stability - WHO recommends administration **within 3 hours** of PPH onset as an adjunct therapy - While useful in PPH management, it does **not address uterine atony** (the primary cause indicated by soft uterus) - Should be given **in addition to uterotonics**, not as a substitute for definitive management of atony

Q: A G2 P1 - 29-year-old female delivered a baby, but the baby died within 48 hours due to medical reasons. What drug will you advise to stop breast milk secretion?

Cabergoline. ***Cabergoline*** - **Cabergoline** is a **non-ergot dopamine agonist** that effectively inhibits pituitary prolactin secretion, leading to the suppression of lactation. - It works by acting on **D2 dopamine receptors** in the pituitary gland, thereby preventing milk secretion after delivery. - It is the **preferred first-line agent** for lactation suppression due to its superior efficacy, better tolerability, longer half-life (allowing single or twice-daily dosing over 2 days), and lower side effect profile. *None of the options* - This option is incorrect because there are specific pharmacological agents available and recommended for **lactation suppression** in such circumstances. - **Cabergoline** is a well-established and commonly used drug for this purpose. *Ergot alkaloids* - While **bromocriptine** (an ergot-derived dopamine agonist) was historically used for lactation suppression, it is no longer preferred. - **Cabergoline** has largely replaced bromocriptine due to better tolerability, longer half-life, less frequent dosing, and fewer side effects (bromocriptine causes more nausea, vomiting, and orthostatic hypotension). - Note: **Cabergoline itself is a non-ergot dopamine agonist**, making it pharmacologically distinct from ergot alkaloids. *Both B & C* - This option is incorrect because **cabergoline is not an ergot alkaloid**—it is a non-ergot dopamine agonist. - While bromocriptine (an ergot derivative) can suppress lactation, **cabergoline alone** is the preferred choice with superior efficacy and safety profile. - Combining or equating these agents is not standard clinical practice.

Q: What are the criteria for administering Anti-D immunoglobulin postpartum in an Rh-negative female?

DCT negative, Baby Rh +ve. ***DCT negative, Baby Rh +ve*** * The mother is **Rh-negative** and needs Anti-D immunoglobulin if her baby is **Rh-positive** to prevent sensitization. * A **negative Direct Coombs Test (DCT)** indicates that the mother has not yet developed antibodies against the baby's Rh-positive red blood cells, making Anti-D administration effective for prevention. * *DCT positive, Baby Rh +ve* * If the **DCT is positive**, it means the mother has already formed **antibodies** against the baby's Rh-positive red blood cells (sensitization has occurred). * In this scenario, administering Anti-D immunoglobulin would be **ineffective** as the immune response has already begun. * *DCT negative, Baby Rh -ve* * If the baby is **Rh-negative**, there is no risk of Rh sensitization for an Rh-negative mother. * Therefore, **Anti-D immunoglobulin is not necessary** in this situation. * *DCT positive, Baby Rh -ve* * A **positive DCT** in an Rh-negative mother implies sensitization has occurred, but it would not be due to an Rh-negative baby. * Administering Anti-D immunoglobulin would be **ineffective** and unnecessary if the baby is Rh-negative.

Q: In a hypertensive patient presenting with postpartum hemorrhage (PPH), which of the following drugs is contraindicated?

Methylergometrine. ***Methylergometrine*** - **Methylergometrine** is an ergot alkaloid that causes potent generalized smooth muscle contraction, including vascular smooth muscle. - In a hypertensive patient, this can lead to a significant and dangerous increase in **blood pressure** and subsequent complications like stroke. *PGF-2 alpha* - **Prostaglandin F2 alpha (Carboprost)** can cause transient increases in blood pressure, but it is generally considered safe for use in carefully selected hypertensive patients for PPH. - Its primary contraindication is in patients with **asthma** due to its bronchoconstrictive effects. *Oxytocin* - **Oxytocin** is often the first-line uterotonic for PPH and is generally safe in hypertensive patients, although rapid IV bolus can cause transient hypotension or tachycardia. - It works by stimulating uterine contractions and has minimal direct effects on **systemic vascular resistance**. *Misoprostol* - **Misoprostol** is a prostaglandin E1 analog that can be used effectively for PPH and is generally safe in hypertensive patients. - Its main side effects include **fever** and **chills**, and it does not typically cause significant changes in blood pressure.

Q: A 26-year-old woman who is breastfeeding presents with a painful, red, swollen breast and has a fever. What is the most likely diagnosis?

Mastitis. ***Mastitis*** - This presentation of a **painful, red, swollen breast** with **fever** in a **breastfeeding woman** is classic for **puerperal mastitis**. - It is often caused by bacterial infection, usually *Staphylococcus aureus*, which enters through a cracked nipple. *Breast abscess* - While a breast abscess can present with similar symptoms, it is typically a **complication of untreated mastitis** and usually presents with a **fluctuant mass** that is not described here. - The initial presentation aligns more with uncomplicated mastitis, which can progress to an abscess if not treated. *Inflammatory breast cancer* - This is a rare and aggressive form of breast cancer that can mimic mastitis with **redness, swelling, and warmth** (peau d'orange). - However, it typically occurs in **older women**, is usually **not associated with fever** in the acute presentation, and is **not related to breastfeeding**. *Fibrocystic change* - This is a **benign condition** characterized by **lumpy, painful breasts**, often fluctuating with the menstrual cycle. - It does **not typically present with redness, swelling, or fever** and is not an infectious process.

Q: What is the definitive surgical treatment for severe postpartum hemorrhage due to uterine atony when conservative measures and fertility-sparing procedures have failed?

Hysterectomy. ***Hysterectomy*** - **Hysterectomy** offers a definitive resolution for severe **postpartum hemorrhage** due to **uterine atony** when all other conservative and surgical measures have failed to control bleeding. - While it results in loss of fertility, it is a life-saving procedure due to its effectiveness in stopping uncontrollable uterine bleeding. *Uterine artery embolization* - **Uterine artery embolization** is a less invasive option but is primarily used for conditions like **fibroids** or **adenomyosis**, or in cases of persistent hemorrhage after initial medical management has failed, but not typically as the *most effective surgical treatment* for active, severe atony that requires immediate intervention. - It usually takes time for the effects to manifest and might not be fast enough for heavy, uncontrolled bleeding in an emergency. *Bilateral oophorectomy* - **Bilateral oophorectomy**, the removal of both ovaries, is not indicated for **uterine atony** because the ovaries are not directly involved in the bleeding from the uterus. - This procedure would significantly alter the patient's hormonal balance without addressing the source of the hemorrhage. *Cervical cerclage* - **Cervical cerclage** is a surgical procedure used to prevent premature birth by reinforcing a weakened cervix during pregnancy, and is entirely unrelated to managing **postpartum hemorrhage** or **uterine atony**. - It is an antepartum intervention and has no role in immediate postpartum bleeding control.

Q: A 28-year-old woman presents with severe postpartum hemorrhage that is unresponsive to uterotonics. What is the next step in management?

Balloon tamponade. ***Balloon tamponade*** - **Uterine balloon tamponade** is a minimally invasive and effective intervention for postpartum hemorrhage unresponsive to uterotonics, providing mechanical compression to the uterine walls and promoting hemostasis. - It is typically considered a **first-line surgical intervention** before more invasive procedures, suitable for cases of **uterine atony** or retained placental fragments without uterine rupture. *B-Lynch suture* - A **B-Lynch suture** is a surgical technique involving uterine compression sutures, generally reserved for cases where balloon tamponade has failed or is deemed insufficient. - This procedure requires expertise in surgical skills and is more invasive than balloon tamponade, often performed when direct visualization and repair of the uterus are necessary. *Hysterectomy* - **Hysterectomy** is a last resort to control intractable postpartum hemorrhage and is considered when all other conservative and surgical measures have failed, often due to severe and life-threatening bleeding. - It results in **loss of fertility** and is a major surgical procedure with higher risks compared to less invasive options. *Uterine artery embolization* - **Uterine artery embolization** is a radiological procedure that involves blocking blood flow to the uterus, mainly used for persistent postpartum hemorrhage after other treatments have failed or in cases where surgical intervention is difficult. - This procedure requires an **interventional radiologist** and is not immediately available in all settings, making it less suitable as a first-line option for acute, severe hemorrhage.

Q: In a patient with postpartum endometritis, what is the most appropriate antibiotic therapy?

Clindamycin plus gentamicin. ***Clindamycin plus gentamicin*** - This combination provides broad-spectrum coverage against the typical polymicrobial infection causing **postpartum endometritis**, including **anaerobes** (Clindamycin) and **gram-negative bacteria** (gentamicin). - It is the **recommended empiric first-line therapy** due to its efficacy in achieving clinical improvement within 24-48 hours. *Metronidazole alone* - Metronidazole primarily covers **anaerobic bacteria**, which are a component of postpartum endometritis, but it lacks coverage for significant **gram-positive** and **gram-negative aerobic bacteria** commonly involved. - Using metronidazole alone would lead to **inadequate treatment** and potential treatment failure due to insufficient broad-spectrum activity. *Amoxicillin* - Amoxicillin is a **penicillin-class antibiotic** with good activity against some gram-positive and certain gram-negative bacteria, but it has limited activity against many **anaerobes** and certain **gram-negative organisms** frequently implicated in endometritis. - It would not provide the **broad-spectrum coverage** necessary for a polymicrobial infection like postpartum endometritis. *Ciprofloxacin* - Ciprofloxacin is a **fluoroquinolone** primarily effective against **gram-negative bacteria** and some atypical organisms, but it has **poor anaerobic coverage** and variable activity against gram-positive bacteria. - Its spectrum of activity is **insufficient** for the comprehensive treatment of postpartum endometritis, which almost always involves anaerobes.

Question 1

All of the following drugs are used for prevention of PPH, EXCEPT:

Accepted Answer

Dinoprostone

Answer

Misoprostol

Answer

Oxytocin

Answer

PGF-2 alpha

Question 2

A 28-year-old postpartum woman presents with uterine atony and heavy bleeding. Which medication should be avoided due to a history of hypertension?

Accepted Answer

Methylergonovine

Answer

Carboprost

Answer

Misoprostol

Answer

Oxytocin

Question 3

A 28-year-old woman, G2 P1, with severe PPH unresponsive to oxytocin presents with hypotension and tachycardia. She has a soft uterus and ongoing bleeding. What is the next best step in management?

Accepted Answer

IM carboprost

Answer

Immediate hysterectomy

Answer

Expectant management

Answer

IV tranexamic acid

Question 4

A G2 P1 - 29-year-old female delivered a baby, but the baby died within 48 hours due to medical reasons. What drug will you advise to stop breast milk secretion?

Accepted Answer

Cabergoline

Answer

None of the options

Answer

Ergot alkaloids

Answer

Both B & C

Question 5

What are the criteria for administering Anti-D immunoglobulin postpartum in an Rh-negative female?

Accepted Answer

DCT negative, Baby Rh +ve

Answer

DCT positive, Baby Rh +ve

Answer

DCT negative, Baby Rh -ve

Answer

DCT positive, Baby Rh -ve

Question 6

In a hypertensive patient presenting with postpartum hemorrhage (PPH), which of the following drugs is contraindicated?

Accepted Answer

Methylergometrine

Answer

PGF-2 alpha

Answer

Oxytocin

Answer

Misoprostol

Question 7

A 26-year-old woman who is breastfeeding presents with a painful, red, swollen breast and has a fever. What is the most likely diagnosis?

Accepted Answer

Mastitis

Answer

Breast abscess

Answer

Inflammatory breast cancer

Answer

Fibrocystic change

Question 8

What is the definitive surgical treatment for severe postpartum hemorrhage due to uterine atony when conservative measures and fertility-sparing procedures have failed?

Accepted Answer

Hysterectomy

Answer

Uterine artery embolization

Answer

Bilateral oophorectomy

Answer

Cervical cerclage

Question 9

A 28-year-old woman presents with severe postpartum hemorrhage that is unresponsive to uterotonics. What is the next step in management?

Accepted Answer

Balloon tamponade

Answer

B-Lynch suture

Answer

Hysterectomy

Answer

Uterine artery embolization

Question 10

In a patient with postpartum endometritis, what is the most appropriate antibiotic therapy?

Accepted Answer

Clindamycin plus gentamicin

Answer

Metronidazole alone

Answer

Amoxicillin

Answer

Ciprofloxacin

Postpartum Care — MCQs

Postpartum Care — MCQs

On this page

Practice by Chapter

Want unlimited practice?